HOPE Summit III

Hematology & Oncology Practice Exchange Summit III

  • 14 November 2026
  • Virtual Meeting
  • Accredited CME

A scientific exchange for invited healthcare professionals, with parallel Oncology and Hematology programmes.

Enter the Conference Explore the Scientific Agenda

Join us online on 14 November 2026. The opening time will be confirmed here.

Organized byAmgen

14 November 2026 · Virtual Meeting

Conference access

Join us online on 14 November 2026. The opening time will be confirmed here.

Register How to attend

HOPE Summit III

About HOPE Summit III

HOPE, the Hematology & Oncology Practice Exchange, returns for its third summit as a virtual meeting on 14 November 2026, organized by Amgen.

The programme runs two parallel tracks. The Oncology track covers updates in thoracic and gastrointestinal oncology, the treatment journey in small cell lung cancer, and precision oncology in mCRC. The Hematology track covers Ph-negative and Ph-positive ALL in adult and paediatric care, and multiple myeloma and ITP.

The summit is a personal invitation for invited healthcare professionals.

TrackOncology
TrackHematology

Programme · 14 November 2026

Scientific agenda

All times are Riyadh time (Asia/Riyadh).

Download the agenda (PDF)

Hema/Onco Welcoming Session

09:50 – 10:00Hema/Onco Welcoming Session
  1. 09:50 – 10:00

    Opening

Oncology

10:00 – 11:10Session 1: ASCO & ESMO 2026 Updates in Thoracic and Gastrointestinal OncologyModerator:
  1. 10:00 – 10:20

    ASCO & ESMO 2026 Highlights in Thoracic Oncology

  2. 10:20 – 10:40

    ASCO & ESMO 2026 Highlights in GI Oncology

  3. 10:40 – 11:00

    ASCO & ESMO 2026 Highlights in mCRC: Precision Oncology and Emerging Treatment Paradigms

  4. 11:00 – 11:10

    Panel Discussion

11:10 – 13:45Session 2: Optimizing the Treatment Journey in Small Cell Lung CancerModerators: , ,
  1. 11:10 – 11:30

    SCLC landscape: Epidemiology, Disease Burden, Relapse Patterns, Unmet Needs, and Emerging First-Line Maintenance Evidence (DeLLphi-305; Investigational)

    Moderator:

  2. 11:30 – 11:50

    DLL3 Biology and Rationale for Targeted Immunotherapy

    Moderator:

  3. 11:50 – 12:10

    DeLLphi-304: Phase 3 Evaluation of Tarlatamab in Second-Line SCLC (Investigational)

    Moderator:

  4. 12:10 – 12:30

    Patient Selection, Step-Up Dosing, Administration, and Monitoring in Relapsed SCLC

    Moderator:

  5. 12:30 – 12:50

    Panel Discussion

  6. 12:50 – 13:00

    Prayer and Break

  7. 13:00 – 13:20

    Managing CRS and ICANS: Clinical Insights and Best Practices

    Moderator:

  8. 13:20 – 13:35

    DeLLphi-308: Phase 1b Evaluation of Subcutaneous Tarlatamab in ES-SCLC (Investigational)

    Moderator:

  9. 13:35 – 13:45

    Panel Discussion

13:45 – 14:55Session 3: Precision Oncology and Treatment Optimization in mCRCModerator:
  1. 13:45 – 14:05

    Optimizing Anti-EGFR Therapy in First Line and Maintenance

  2. 14:05 – 14:25

    Dual Pathway Inhibition in KRAS G12C mCRC: Sotorasib Plus Panitumumab

  3. 14:25 – 14:45

    Anti-EGFR Re-Challenge in mCRC: Patient Selection and Clinical Evidence

  4. 14:45 – 14:55

    Panel Discussion

14:55 – 16:40Session 4: Expert Case Discussions and Real-World Practice in SCLC & mCRCModerators: ,
  1. 14:55 – 15:10

    Tarlatamab Patient Selection and Sequencing in Relapsed SCLC — Case 1

    Moderator:

  2. 15:10 – 15:25

    Case 2: Durable Complete Response with Tarlatamab in ES-SCLC

    Moderator:

  3. 15:25 – 15:35

    Break

  4. 15:35 – 15:50

    Real-World Clinical Experience with Sotorasib in KRAS G12C-Mutated mCRC

    Moderator:

  5. 15:50 – 16:05

    KRAS G12C-Mutated mCRC: Treatment with Sotorasib Plus Panitumumab

    Moderator:

  6. 16:05 – 16:20

    Real-World Panitumumab Experience in mCRC: Treatment and Maintenance

    Moderator:

  7. 16:20 – 16:40

    Panel Discussion

16:40 – 17:00Closing Remarks and Meeting Close

Hematology

10:00 – 11:15Session 1: Optimizing Ph-ve ALL Treatment ( Adult/Pedia )Moderator:
  1. 10:00 – 10:20

    Adult Ph-Negative ALL: Deeper Remissions and Improved Treatment in Front Line

  2. 10:20 – 10:40

    Saudi Pediatric ALL Consensus 2026

  3. 10:40 – 11:00

    How I Treat Adult Ph-Negative (NGH Followed Protocol)

  4. 11:00 – 11:15

    Panel Discussion

11:15 – 12:30Session 2: Optimizing Ph+ve ALL Treatment ( Adult/Pedia )Moderator:
  1. 11:15 – 11:35

    Adult Ph-Positive ALL: Chemo-Free Approaches in Front Line - Combination Therapy

  2. 11:35 – 11:55

    Managing Immunotherapy Toxicities in Clinical Practice

  3. 11:55 – 12:15

    How I Treat Pediatric Ph-Positive ALL (NGH Followed Protocol)

  4. 12:15 – 12:30

    Panel Discussion

12:30 – 12:45Prayer & Break
12:45 – 13:45Session 3: Optimizing ALL Patients Treatment Journey ( Adult/Pedia )Moderator:
  1. 12:45 – 13:10

    Updates in Management of Ph - ALL

  2. 13:10 – 13:30

    Management Strategies for Ph - B-Cell ALL in Pediatric: the KASCH-NGHA Experience

  3. 13:30 – 13:45

    Panel Discussion

13:45 – 14:00Break
14:00 – 15:00Session 4 : Multiple Myeloma / ITPModerator:
  1. 14:00 – 14:25

    Quadruplet Therapy in Newly Diagnosed Multiple Myeloma: Are We Ready for a New Standard?

  2. 14:25 – 14:45

    Long-Term Outcomes and Treatment-Free Remission in ITP

  3. 14:45 – 15:00

    Panel Discussion

15:00Closing Remarks

40 speakers and moderators

Faculty

Previous editions

Previous HOPE Summits

HOPE Summit I

Photos and videos from HOPE Summit I will be published here.

HOPE Summit II

Photos and videos from HOPE Summit II will be published here.

Virtual Meeting · 14 November 2026

Register

Complete the form to register for HOPE Summit III.

Fields marked * are required. Your details are used to register you for this meeting and are sent to the HOPE conference platform to create your access.

Joining online

How to attend

  1. 1

    Register

    Complete the registration form on this page.

  2. 2

    Receive your access details

    The conference platform emails your sign-in details to the address you registered with.

  3. 3

    Join on 14 November

    Select “Enter the Conference” and sign in with your mobile number and PIN.